These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 17339340)

  • 1. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
    Goetz R; Beenken A; Ibrahimi OA; Kalinina J; Olsen SK; Eliseenkova AV; Xu C; Neubert TA; Zhang F; Linhardt RJ; Yu X; White KE; Inagaki T; Kliewer SA; Yamamoto M; Kurosu H; Ogawa Y; Kuro-o M; Lanske B; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2007 May; 27(9):3417-28. PubMed ID: 17339340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural biology of the FGF19 subfamily.
    Beenken A; Mohammadi M
    Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
    Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H; Kuro-o M
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
    Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
    Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FGF metabolic axis.
    Li X
    Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-receptor requirements for fibroblast growth factor-19 signaling.
    Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.
    Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M
    J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity.
    Harmer NJ; Pellegrini L; Chirgadze D; Fernandez-Recio J; Blundell TL
    Biochemistry; 2004 Jan; 43(3):629-40. PubMed ID: 14730967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mini-review: endocrine actions of fibroblast growth factor 19.
    Jones S
    Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.
    Goetz R; Ohnishi M; Ding X; Kurosu H; Wang L; Akiyoshi J; Ma J; Gai W; Sidis Y; Pitteloud N; Kuro-O M; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2012 May; 32(10):1944-54. PubMed ID: 22451487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology of FGF15/19.
    Jones SA
    Adv Exp Med Biol; 2012; 728():171-82. PubMed ID: 22396169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.
    Itoh N
    Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Structure-Function Paradigm of Endocrine FGFs in Metabolic Diseases.
    Luo Y; Ye S; Li X; Lu W
    Trends Pharmacol Sci; 2019 Feb; 40(2):142-153. PubMed ID: 30616873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Saga of Endocrine FGFs.
    Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
    Kurosu H; Kuro-O M
    Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.
    Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M
    Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine fibroblast growth factors as regulators of metabolic homeostasis.
    Kurosu H; Kuro-O M
    Biofactors; 2009; 35(1):52-60. PubMed ID: 19319846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine FGFs and Klothos: emerging concepts.
    Kuro-o M
    Trends Endocrinol Metab; 2008 Sep; 19(7):239-45. PubMed ID: 18692401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho and βKlotho.
    Kuro-o M
    Adv Exp Med Biol; 2012; 728():25-40. PubMed ID: 22396160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.